Denis Drygin - Feb 4, 2022 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Signature
Christopher Aker, Attorney in Fact
Stock symbol
RGLS
Transactions as of
Feb 4, 2022
Transactions value $
$5,362
Form type
4
Date filed
2/7/2022, 04:09 PM
Previous filing
Jan 26, 2022
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Purchase $5.36K +23.3K $0.23 23.3K Feb 4, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.